Literature DB >> 28302281

The art and science of pediatric damage control.

Anthony Tran1, Brendan T Campbell2.   

Abstract

Damage control is a surgical strategy that has evolved and expanded considerably over the past 25 years. The approach was initially developed as a "bail out" procedure to control bleeding with severe abdominal injuries in the setting of unmitigated hemorrhagic shock. Damage control is now more broadly applied as a comprehensive management plan for the resuscitation and surgical treatment of injured patients with exhausted physiologic and metabolic reserve. This article reviews the most current concepts in damage control that are important and relevant to the practicing pediatric surgeon. It also provides evidence-based recommendations about how damage control principles can be pragmatically applied to severely injured children. This review focuses specifically on the fundamentals of damage control with respect to resuscitation and the operative treatment of children with severe abdominal, thoracic, and extremity injuries.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Damage control; Massive transfusion; Pediatric trauma; Shock

Mesh:

Year:  2017        PMID: 28302281     DOI: 10.1053/j.sempedsurg.2017.01.005

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  2 in total

1.  Association of Blood Component Ratios With 24-Hour Mortality in Injured Children Receiving Massive Transfusion.

Authors:  Elissa K Butler; Brianna M Mills; Saman Arbabi; Eileen M Bulger; Monica S Vavilala; Jonathan I Groner; Lynn G Stansbury; John R Hess; Frederick P Rivara
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

2.  Damage control orthopedics applied in an 8-year-old child with life-threatening multiple injuries: A CARE-compliant case report.

Authors:  Viktoria Amanda Pfeifle; Simone Schreiner; Daniel Trachsel; Stefan Gerhard Holland-Cunz; Johannes Mayr
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.